Ryan B. Corcoran

机构：Harvard University, Massachusetts General Hospital, Global Cancer Institute, Center for Cancer Research · ORCID：0000-0001-8173-5778

发表论文 731 篇 · 总被引 23201 次 · h-index 63

代表论文

• Genomic landscape of clinically acquired resistance alterations in patients treated with KRASG12C inhibitors (2025 · Annals of Oncology · 被引 57)
• TOP1 Mutations and Cross-Resistance to Antibody–Drug Conjugates in Patients with Metastatic Breast Cancer (2025 · Clinical Cancer Research · 被引 46)
• Phase 1/2 trial of encorafenib, cetuximab, and nivolumab in microsatellite stable BRAFV600E metastatic colorectal cancer (2025 · Cancer Cell · 被引 24)
• Emerging landscape of KRAS inhibitors in cancer treatment (2026 · Cancer Cell · 被引 18)
• Acquired On-Target Alterations Drive Clinical Resistance to p53-Y220C Reactivators (2026 · Cancer Discovery · 被引 5)
• MAPK Pathway Mutations Emerge in Mutant IDH1 Inhibitor–Resistant Cholangiocarcinoma and Attenuate the IFN Response (2025 · Clinical Cancer Research · 被引 4)